Company: LHI
Filing Date: 2025-09-29
Form Type: F-1/A
Source: 0001213900-25-092499
Chunk: 20

Company: Living Homeopathy International Ltd.
Filing Date: 2025-09-29
Form: F-1/A
Chunk 20
---
 in effecting service of legal process,   
 enforcing foreign judgments or bringing actions in Hong Kong against Living Homeopathy or    
 its management named in the prospectus based on Hong Kong laws. See more detailed discussion 
 of this risk factor on page 38 of this prospectus.                                           |

| ● | We                                                                                       
 may be affected by the currency peg system in Hong Kong. See more detailed discussion of 
 this risk factor on page 38 of this prospectus.                                          |

Risks Related to This Offering and the Class A Ordinary Shares In addition to the risks described above, we are subject to general risks and uncertainties relating to this offering and the Class A Ordinary Shares, including, but not limited to, the following:

| ● | There                                                                                     
 has been no public market for our Class A Ordinary Shares prior to this offering, and you 
 may not be able to resell the Class A Ordinary Shares at or above the price you paid, or  
 at all. See more detailed discussion of this risk factor on page 38 of this prospectus.   |

<div align='center'>6</div>

| ● | The                                                                                        
 recent joint statement by the SEC, proposed rule changes submitted by Nasdaq, and an act   
 passed by the U.S. Senate and the U.S. House of Representatives, all call for additional   
 and more stringent criteria to be applied to emerging market companies. These developments 
 could add uncertainties to our offering, business operations, share price and reputation.  
 See more detailed discussion of this risk factor on page 40 of this prospectus.            |

| ● | Nasdaq                                                                                      
 may apply additional and more stringent criteria for Living Homeopathy’s initial and        
 continued listing because Living Homeopathy plan to have a small public offering and Living 
 Homeopathy insiders will hold a large portion of its listed securities. See more detailed   
 discussion of this risk factor on page 40 of this prospectus.                               |

| ● | Our                                                                                              
 Class A Ordinary Shares may be thinly traded and you may be unable to sell at or near ask        
 prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate 
 your shares. See more detailed discussion of this risk factor on page 41 of this prospectus.     |

| ● | The                                                                                        
 market price for the Class A Ordinary Shares may be volatile. See more detailed discussion 
 of this risk factor on page 41 of this prospectus.                                         |

| ● | We                                                                                                
 may experience extreme stock price volatility unrelated to our actual